Page last updated: 2024-08-25

coptisine and Irritable Bowel Syndrome

coptisine has been researched along with Irritable Bowel Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, C; Jiao, L; Tan, Y; Wei, H; Xiong, Y; Zeng, L; Zhang, J	1

Other Studies

1 other study(ies) available for coptisine and Irritable Bowel Syndrome

Article	Year
Coptisine attenuates post‑infectious IBS via Nrf2‑dependent inhibition of the NLPR3 inflammasome. Molecular medicine reports, 2022, Volume: 26, Issue:6 Topics: Animals; Anti-Inflammatory Agents; Caspase 1; Cytokines; Deoxyguanosine; Heme Oxygenase-1; Inflammasomes; Interleukin-18; Irritable Bowel Syndrome; Isoquinolines; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Tumor Necrosis Factor-alpha	2022

Article

Year

Coptisine attenuates post‑infectious IBS via Nrf2‑dependent inhibition of the NLPR3 inflammasome.

Molecular medicine reports, 2022, Volume: 26, Issue:6

Topics: Animals; Anti-Inflammatory Agents; Caspase 1; Cytokines; Deoxyguanosine; Heme Oxygenase-1; Inflammasomes; Interleukin-18; Irritable Bowel Syndrome; Isoquinolines; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Tumor Necrosis Factor-alpha

2022